Author:
Torres Keila E.,Pollock Raphael E.
Reference101 articles.
1. Allander, S.V., Illei, P.B., Chen, Y., Antonescu, C.R., Bittner, M., Ladanyi, M., and Meltzer, P.S. (2002). Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol 161, 1587–1595.
2. Alman, B.A., Li, C., Pajerski, M.E., Diaz-Cano, S., and Wolfe, H.J. (1997). Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151, 329–334.
3. Antonescu, C.R., Nafa, K., Segal, N.H., Dal Cin, P., and Ladanyi, M. (2006). EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 12, 5356–5362.
4. Breaker, R.R., and Joyce, G.F. (1994). A DNA enzyme that cleaves RNA. Chem Biol 1, 223–229.
5. Chawla, S.P., Chua, V.S., Fernandez, L., Quon, D., Saralou, A., Blackwelder, W.C., Hall, F.L., and Gordon, E.M. (2009). Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcoma. Mol Ther 17, 1651–1657.